Home/Filings/4/0001209191-22-010797
4//SEC Filing

Goswami Trishna 4

Accession 0001209191-22-010797

CIK 0001740279other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:39 PM ET

Size

5.7 KB

Accession

0001209191-22-010797

Insider Transaction Report

Form 4
Period: 2022-02-15
Goswami Trishna
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-02-15+90,50090,500 total
    Exercise: $4.28Exp: 2032-02-15Common Stock (90,500 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on February 15, 2023 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

IN8BIO, INC.

CIK 0001740279

Entity typeother

Related Parties

1
  • filerCIK 0001894243

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:39 PM ET
Size
5.7 KB